Agnathia-holoprosencephaly-situs inversus syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:990OMIM:202650Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Agnathia-holoprosencephaly-situs inversus syndrome, also known as agnathia-otocephaly complex or otocephaly, is an extremely rare and typically lethal congenital malformation syndrome. It is characterized by three cardinal features: agnathia (absence or severe underdevelopment of the mandible/lower jaw), holoprosencephaly (a failure of the forebrain to properly divide into two hemispheres), and situs inversus (a mirror-image reversal of the normal positioning of internal organs). The condition profoundly affects craniofacial development, the central nervous system, and visceral organ arrangement. Key clinical features include absence or severe hypoplasia of the mandible, microstomia (abnormally small mouth) or astomia (absence of the mouth), synotia (fusion or medial displacement of the ears, sometimes beneath the chin), and varying degrees of holoprosencephaly ranging from alobar to semilobar forms. Additional findings may include cyclopia or other ocular anomalies, absence of the tongue (aglossia), and abnormalities of the pharynx and upper airway. Situs inversus totalis or other laterality defects are variably present. The condition is almost invariably fatal in the perinatal period due to severe airway compromise and brain malformations. The etiology remains incompletely understood. Most reported cases are sporadic, though some evidence suggests possible autosomal recessive inheritance in rare familial cases. Mutations in the PRRX1 gene have been implicated in some cases of otocephaly. Diagnosis is typically made prenatally via ultrasound or at birth based on the characteristic physical findings. There is no curative treatment; management is supportive and palliative. Genetic counseling is recommended for affected families.

Clinical phenotype terms— hover any for plain English:

MicroglossiaHP:0000171Situs inversus totalisHP:0001696CyclopiaHP:0009914Aplasia/Hypoplasia involving the noseHP:0009924Mandibular aplasiaHP:0009939Narrow internal auditory canalHP:0011386Absent naresHP:0100596SynotiaHP:0100663
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Agnathia-holoprosencephaly-situs inversus syndrome.

View clinical trials →

No actively recruiting trials found for Agnathia-holoprosencephaly-situs inversus syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Agnathia-holoprosencephaly-situs inversus syndrome community →

No specialists are currently listed for Agnathia-holoprosencephaly-situs inversus syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Agnathia-holoprosencephaly-situs inversus syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Agnathia-holoprosencephaly-situs inversus syndromeForum →

No community posts yet. Be the first to share your experience with Agnathia-holoprosencephaly-situs inversus syndrome.

Start the conversation →

Latest news about Agnathia-holoprosencephaly-situs inversus syndrome

No recent news articles for Agnathia-holoprosencephaly-situs inversus syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Agnathia-holoprosencephaly-situs inversus syndrome

What is Agnathia-holoprosencephaly-situs inversus syndrome?

Agnathia-holoprosencephaly-situs inversus syndrome, also known as agnathia-otocephaly complex or otocephaly, is an extremely rare and typically lethal congenital malformation syndrome. It is characterized by three cardinal features: agnathia (absence or severe underdevelopment of the mandible/lower jaw), holoprosencephaly (a failure of the forebrain to properly divide into two hemispheres), and situs inversus (a mirror-image reversal of the normal positioning of internal organs). The condition profoundly affects craniofacial development, the central nervous system, and visceral organ arrangeme

At what age does Agnathia-holoprosencephaly-situs inversus syndrome typically begin?

Typical onset of Agnathia-holoprosencephaly-situs inversus syndrome is neonatal. Age of onset can vary across affected individuals.